[Conference Materials, Panel to Review GP-160 Vaccine Candidate (1992: Bethesda, Maryland)]

2. BASED ON THE SCIENTIFIC MERIT OF THE GP-160 VACCINE, SHOULD A LARGE-SCALE EFFICACY TRIAL BE INITIATED AT THIS TIME IN HIV SEROPOSITIVE INDIVIDUALS? 3. SINCE NO FORMAL PROTOCOL IS AVAILABLE AT THIS TIME, WHAT SHOULD THE ROLE OF NIH BE OVER THE NEXT SIX MONTHS IN REVIEWING POTENTIAL PROTOCOL DESIGNS? 4. SHOULD CONSIDERATION BE GIVEN TO INCLUDING SEVERAL PROMISING VACCINE CANDIDATES IN A LARGESCALE, COMPARATIVE EFFICACY TRIAL? ARE ADDITIONAL CANDIDATES READY FOR PHASE III TESTING? WHAT WOULD BE THE OBJECTIVE, RATIONALE, AND OPTIMUM DESIGN OF SUCH A COMPARATIVE TRIAL? ALL OF THESE ISSUES FOR DISCUSSION MUST BE DRIVEN BY THE PROCESS OF OBJECTIVE SCIENTIFIC 8

/ 35

Actions

file_download Download Options Download this page PDF - Pages #1-35 Image - Page 8 Plain Text - Page 8

About this Item

Title
[Conference Materials, Panel to Review GP-160 Vaccine Candidate (1992: Bethesda, Maryland)]
Author
National Institutes of Health (U.S.)
Canvas
Page 8
Publication
1992-11-05
Subject terms
press kits
Item type:
press kits

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0463.003
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0463.003/12

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0463.003

Cite this Item

Full citation
"[Conference Materials, Panel to Review GP-160 Vaccine Candidate (1992: Bethesda, Maryland)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0463.003. University of Michigan Library Digital Collections. Accessed June 7, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel